CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
85 hedge funds and large institutions have $239M invested in Concert Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 25 increasing their positions, 28 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% less funds holding
Funds holding: 89 → 85 (-4)
11% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 28
Holders
85
Holding in Top 10
3
Calls
$879K
Puts
$788K
Top Buyers
| 1 | +$37.5M | |
| 2 | +$18.9M | |
| 3 | +$7.35M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.59M |
| 5 |
D.E. Shaw & Co
New York
|
+$4.01M |
Top Sellers
| 1 | -$6.96M | |
| 2 | -$5.54M | |
| 3 | -$4.77M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.63M |
| 5 |
NC
Nexthera Capital
New York
|
-$1.73M |